Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 2022

View Archived Issues

Novel microRNA panel predicts immunotherapy efficacy in NSCLC

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical patents ADCs targeting B7-H3

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors

New pantetheinase inhibitors discovered at Shanghai Meiyue Biotech Development

Shanghai Institute of Materia Medica describes thyroid hormone receptor agonists

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

Novel vaccination strategy using AMP-CpG against EBV infection shows promise in vivo

Explant glioblastoma model may allow early precision treatment of patients

Aramchol shows effects in preclinical models of lung and gastrointestinal fibrosis

DS-17701585, EP300/CBP inhibitor with efficacy in lung squamous cell carcinoma xenograft

GLP-1R agonist PF-1801 seen useful to treat polymyositis

Oral and topical CF-602 significantly reduces erectile dysfunction in vivo

Researchers develop a hepatitis E model in rats

Limitations of certain mouse models for sickle cell research highlighted

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...